The US government is being urged to take action over soaring insulin prices in America.
About Erica Mitchell
This author has yet to write their bio.Meanwhile lets just say that we are proud Erica Mitchell contributed a whooping 220 entries.
Entries by Erica Mitchell
U.S. officials need to take action to control spiking insulin prices, the American Medical Association (AMA) says.
Almost half of diabetics in America have cut back on treatment at some point due to the price of insulin hitting new heights.
Almost half of diabetics are cutting back on treatment because of costs, according to a new survey that comes as the skyrocketing price of insulin is prompting lawmakers and physicians to call for more oversight.
As rising drug prices became a hot political issue, Yvanna Cancela was looking for a way to make a difference. So early last year, the Nevada state senator introduced a transparency bill that would require drugmakers to report pricing, costs, and rebates—but only concerning diabetes medications.
According to a new study completed by the American Diabetes Association, the total cost of diagnosed diabetes for 2017 was estimated at $327 billion.
The American Diabetes Association (ADA) has issued a public policy statement that outlines long- and short-term recommendations for improving insulin affordability.
Alec Smith was diagnosed with type 1 diabetes shortly before his 24th birthday. When he turned 26, he lost his health insurance. Less than a month later, he lost his life because he couldn’t afford the exorbitant price of his life-saving insulin.
The American Diabetes Association (ADA) released a set of policy recommendations designed to spotlight the increasing difficulties patients with diabetes have affording insulin or gaining access to the life-saving medication through health insurance.
In a new policy statement, the American Diabetes Association (ADA) provides specific short- and long-term recommendations for improving insulin access and affordability.